Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface
- 1 December 1997
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 38 (1-2) , 119-127
- https://doi.org/10.1016/s0162-3109(97)00064-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Complement activation during cardiopulmonary bypass: Effects of immobilized heparinThe Annals of Thoracic Surgery, 1994
- Evidence for iC3 generation during cardiopulmonary bypass as the result of blood-gas interactionClinical and Experimental Immunology, 1993
- Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Assessing the effect of cardiopulmonary bypass on the brainThe Annals of Thoracic Surgery, 1991
- The response of human platelets to activated components of the complement systemImmunology Today, 1991
- Formation of C5a during cardiopulmonary bypass: Inhibition by precoating with heparinThe Annals of Thoracic Surgery, 1991
- Transient adhesion of neutrophils to endothelium.The Journal of Experimental Medicine, 1989
- Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium.Journal of Clinical Investigation, 1988
- Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytesThe Journal of Experimental Medicine, 1982
- ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUMThe Journal of Experimental Medicine, 1969